FDA approves new treatment for adult patients with rare, life-threatening blood disease - FDA Press Releases

The FDA approved Ultomiris (ravulizumab) injection for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare and life-threatening blood disease.

from Food and Drug Administration--Press Releases http://bit.ly/2SYb2FY
via IFTTT